Anal cancer - a review
- PMID: 23580899
- PMCID: PMC3616949
- DOI: 10.12816/0006000
Anal cancer - a review
Abstract
Anal cancer accounts for only 1.5% of gastrointestinal malignancies but this disease has shown a steady increase in incidence particularly in HIV positive males. The understanding of pathophysiology and treatment of anal cancer has changed radically over last thirty years. Risk factors have been identified and organ preservation by chemoradiotherapy has become a standard. This article aims to review the clinical presentation, diagnostic evaluation, and treatment options for anal cancer in the light of current literature.
Keywords: HIV; HPV; anal canal; anal cancer; anal margin; chemoradiotherapy; imaging; recurrence; salvage.
References
-
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36. - PubMed
-
- Martin FT, Kavanagh D, Waldron R. Squamous cell carcinoma of the anal canal. Surgeon. 2009;7(4):232–37. - PubMed
-
- Bendell JC, Ryan DP. Current perspectives on anal cancer. Oncology. 2003;17(4):492–97. - PubMed
-
- Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull. 2002;49(3):194–209. - PubMed
-
- Frisch M, Melbye M. Anal cancer. In: Schottenfeld D, editor. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006. pp. 830–40.
LinkOut - more resources
Full Text Sources